1. Ontak Approved to Treat T-Cell Lymphoma - US News and World Report
FRIDAY, Oct. 17 (HealthDay News) -- The Eisai Corp. drug Ontak (denileukin diftitox) has been approved to treat cutaneous T-cell lymphoma (CTCL) whose cells contain a certain receptor known as IL2. A receptor is a molecule found on the surface of ce...

2. Incidence of Mantle Cell Lymphoma on Rise - US News and World Report
FRIDAY, July 18 (HealthDay News) -- The prevalence of mantle cell lymphoma, an aggressive form of non-Hodgkin lymphoma, is increasing, and most patients are diagnosed with advanced stages of the disease, notes a study by researchers at the Universit...

3. B-cell leukemia/lymphoma panel  (Trust Mark: Doctor-Reviewed)
B-cell leukemia/lymphoma panel is a test that looks for certain proteins on the surface of white blood cells called B-lymphocytes. The proteins serve as markers that may be helpful in diagnosing leukemia or lymphoma.• Reviewer: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.